Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
GUILFORD, Conn.--(BUSINESS WIRE)--
Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.
A webcast of the event will be available on the Investors section of Quantum-Si’s website under Events & Presentations. A replay will be available on the Company’s website after the event.
About Quantum-Si
Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
